|
Release Date: August 1, 2005
Available for Credit Through: August 1, 2008
Program Description
Nearly one-third of the population newly diagnosed with epilepsy each year is children. More specifically, 45,000 children under the age of 15 develop epilepsy each year. Classification of seizure disorders has evolved considerably over time and many new treatment options have become available in recent years. For the majority of patients, seizures can be adequately controlled without unendurable side effects. The condition, however, is individualized to each patient and it is important, therefore, that all involved in the care of children with epilepsy are aware of both how to classify a given seizure as well as identify treatment options. Many factors must be considered when choosing a therapeutic regimen for a child with epilepsy, including the efficacy of the drug for the particular seizure type, availability of child-friendly formulations, and dosing, titration and tolerability issues. This program will examine issues and considerations related to identifying seizure types and managing epilepsy in pediatric patients.
|

Click here for a brief preview of this insightful webcast on identifying and treating different seizure types of pediatric epilepsy.
|
|
Target Audience
This activity is intended for neurologists, epileptologists, neurology nurses, pediatricians and other healthcare professionals specializing in the care of pediatric patients.
Program Objectives
Upon completion of this activity, participants should be able to:
- Discuss the latest research findings on the epidemiology and pathophysiology of epilepsy in children
- Review and discuss the different types of seizures among children and current issues regarding management
- Discuss the safety and tolerability of seizure management and understand how to select an appropriate therapeutic regimen to control them
- Understand how to address the condition with parents and loved ones of pediatric epilepsy patients
This program is jointly Sponsored by West Virginia University, School of Medicine and Scinexa, LLC.
This program is supported by an unrestricted educational grant from UCB.
Disclaimer
©2005 Scinexa, LLC. All rights reserved. None of the contents may be reproduced in any form without prior written permission from Scinexa.
The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of UCB, any other manufacturer of pharmaceuticals, West Virginia University, or Scinexa, LLC.
The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.
Printer settings may vary. Please use landscape layout option.

Copyright © 2005 Scinexa, LLC / CME Discovery / ArcMesa Educators, LLC. All rights reserved.
|